Financhill
Sell
20

ASND Quote, Financials, Valuation and Earnings

Last price:
$142.85
Seasonality move :
-2.3%
Day range:
$139.57 - $147.49
52-week range:
$111.09 - $169.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
21.07x
P/B ratio:
--
Volume:
578.6K
Avg. volume:
447.1K
1-year change:
-3.37%
Market cap:
$8.6B
Revenue:
$393.6M
EPS (TTM):
-$7.13

Earnings Data

Next earnings date for ASND
May 02
2025
Most recent earnings per share
-$0.68
Beat by $0.28
(Feb 12/2025)
Consensus Estimate
-$0.96
(Feb 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ASND Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $137.1M -- -- -$1.43 --
05/02/2025 Q1 $102.6M -- -- -$1.64 --
02/12/2025 Q4 $123.2M $185.4M -$0.68 -$0.96 $0.28
11/14/2024 Q3 $76.5M $63.6M -$1.89 -$1.57 -$0.32
09/03/2024 Q2 $94.2M $38.8M -$2.06 -$1.40 -$0.65
05/02/2024 Q1 $85.6M $104.2M -$2.50 -$1.52 -$0.98
02/07/2024 Q4 $92.1M $148.3M -$1.66 -$1.90 $0.24
11/07/2023 Q3 -- -- -$3.14 -$2.37 -$0.76
09/05/2023 Q2 -- -- -$2.36 -$2.80 $0.45
04/27/2023 Q1 -- -- -$2.13 -$2.89 $0.77
02/16/2023 Q4 -- -- -$3.78 -$2.77 -$1.02
11/02/2022 Q3 -- -- -$3.05 -$2.52 -$0.53
08/10/2022 Q2 -- -- -$1.56 -$2.28 $0.73
05/11/2022 Q1 -- -- -$2.48 -$2.15 -$0.33
03/02/2022 Q4 -- -- -$2.14 -$2.59 $0.46
11/10/2021 Q3 -- -- -- -$2.66 --
08/25/2021 Q2 -- -- -$3.01 -$2.64 -$0.37
05/27/2021 Q1 -- -- -$1.41 -$2.27 $0.86
03/10/2021 Q4 -- -- -$3.15 -$1.88 -$1.27
11/11/2020 Q3 -- -- -$2.70 -$1.87 -$0.83
08/27/2020 Q2 -- -- -$2.17 -$1.60 -$0.57
05/19/2020 Q1 -- -- -$1.46 -$1.40 -$0.05
12/31/2019 Q4 -- -- -$1.88 -$1.32 -$0.56
11/18/2019 Q3 -- -- -$0.59 -$1.28 $0.69
08/28/2019 Q2 -- -- -- -$1.33 --
04/03/2019 Q1 -- -- -- -$1.14 --
12/31/2018 Q4 -- -- -- -$1.13 --
11/28/2018 Q3 -- -- -- -$1.20 --
08/29/2018 Q2 -- -- -- -$0.99 --
05/30/2018 Q1 -- -- -- -- --
03/28/2018 Q4 -- -- -- -- --
11/16/2017 Q3 -- -- -- -- --
08/18/2017 Q2 -- -- -- -- --
03/31/2017 Q1 -- -- -- -- --
12/31/2016 Q4 -- -- -- -- --
11/30/2016 Q3 -- -- -- -- --
08/31/2016 Q2 -- -- -- -- --
03/31/2016 Q1 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --
09/30/2015 Q3 -- -- -- -- --
06/30/2015 Q2 -- -- -- -- --

Ascendis Pharma AS Earnings Questions

  • How Much did Ascendis Pharma AS Generate in Revenue Last Quarter?

    Ascendis Pharma AS reported $185.4M worth of top line sales in its most recent quarter.

  • Did Ascendis Pharma AS Beat Earnings Last Quarter?

    Ascendis Pharma AS announced earnings per share of -$0.68 which represents a beat of analyst forecast a -$0.96 per share.

  • Is Ascendis Pharma AS Profitable?

    Ascendis Pharma AS reported $170.4M that represents $2.85 per share over the last quarter.

  • What is the Analyst Consensus for Ascendis Pharma AS EPS Next Year?

    Ascendis Pharma AS's earnings are forecast to decrease from -$7.07 per share to -$3.59 per share next year representing a decrease of -49.27%.

  • When is Ascendis Pharma AS's Earnings Date?

    Ascendis Pharma AS's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do I Need to Know About Alcoa Stock?
What Do I Need to Know About Alcoa Stock?

Alcoa (AA) is a global leader in aluminum production. Based…

Is ROOT Stock the Next Big Thing?
Is ROOT Stock the Next Big Thing?

Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 5

Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.

Sell
25
GDXU alert for Apr 5

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.

Buy
76
SOXS alert for Apr 5

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock